SA
TMO icon

Strategic Advocates’s Thermo Fisher Scientific TMO Stock Holding History

Strategic Advocates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53K Buy
19
+10
+111% +$4.8K 0.04% 162
2026
Q1 		$4.42K Buy
+9
New +$4.88K 0.02% 190

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Strategic Advocates's TMO Position: Q2 2026 in Review

Strategic Advocates increased its Thermo Fisher Scientific (TMO) stake by 111% in Q2 2026, buying an estimated $4.8K and bringing the position to 19 shares worth $9.53K. The position accounts for 0.04% of the portfolio, ranked #162.

Strategic Advocates first reported a position in TMO in Q1 2026 and has held it in 2 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Strategic Advocates held 19 shares of Thermo Fisher Scientific worth $9.53K as of Q2 2026.
  • Strategic Advocates bought 10 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.8K.
  • Thermo Fisher Scientific made up 0.04% of Strategic Advocates's portfolio in Q2 2026, its #162 holding.
  • Strategic Advocates first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 2 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.